UniProt ID | BRD1_HUMAN | |
---|---|---|
UniProt AC | O95696 | |
Protein Name | Bromodomain-containing protein 1 | |
Gene Name | BRD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1058 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.. | |
Protein Sequence | MRRKGRCHRGSAARHPSSPCSVKHSPTRETLTYAQAQRMVEIEIEGRLHRISIFDPLEIILEDDLTAQEMSECNSNKENSERPPVCLRTKRHKNNRVKKKNEALPSAHGTPASASALPEPKVRIVEYSPPSAPRRPPVYYKFIEKSAEELDNEVEYDMDEEDYAWLEIVNEKRKGDCVPAVSQSMFEFLMDRFEKESHCENQKQGEQQSLIDEDAVCCICMDGECQNSNVILFCDMCNLAVHQECYGVPYIPEGQWLCRHCLQSRARPADCVLCPNKGGAFKKTDDDRWGHVVCALWIPEVGFANTVFIEPIDGVRNIPPARWKLTCYLCKQKGVGACIQCHKANCYTAFHVTCAQKAGLYMKMEPVKELTGGGTTFSVRKTAYCDVHTPPGCTRRPLNIYGDVEMKNGVCRKESSVKTVRSTSKVRKKAKKAKKALAEPCAVLPTVCAPYIPPQRLNRIANQVAIQRKKQFVERAHSYWLLKRLSRNGAPLLRRLQSSLQSQRSSQQRENDEEMKAAKEKLKYWQRLRHDLERARLLIELLRKREKLKREQVKVEQVAMELRLTPLTVLLRSVLDQLQDKDPARIFAQPVSLKEVPDYLDHIKHPMDFATMRKRLEAQGYKNLHEFEEDFDLIIDNCMKYNARDTVFYRAAVRLRDQGGVVLRQARREVDSIGLEEASGMHLPERPAAAPRRPFSWEDVDRLLDPANRAHLGLEEQLRELLDMLDLTCAMKSSGSRSKRAKLLKKEIALLRNKLSQQHSQPLPTGPGLEGFEEDGAALGPEAGEEVLPRLETLLQPRKRSRSTCGDSEVEEESPGKRLDAGLTNGFGGARSEQEPGGGLGRKATPRRRCASESSISSSNSPLCDSSFNAPKCGRGKPALVRRHTLEDRSELISCIENGNYAKAARIAAEVGQSSMWISTDAAASVLEPLKVVWAKCSGYPSYPALIIDPKMPRVPGHHNGVTIPAPPLDVLKIGEHMQTKSDEKLFLVLFFDNKRSWQWLPKSKMVPLGIDETIDKLKMMEGRNSSIRKAVRIAFDRAMNHLSRVHGEPTSDLSDID | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | KGRCHRGSAARHPSS CCCCCCCCCCCCCCC | 20.79 | 23312004 | |
17 | Phosphorylation | GSAARHPSSPCSVKH CCCCCCCCCCCCCCC | 40.56 | 22167270 | |
18 | Phosphorylation | SAARHPSSPCSVKHS CCCCCCCCCCCCCCC | 34.08 | 23401153 | |
21 | Phosphorylation | RHPSSPCSVKHSPTR CCCCCCCCCCCCCCH | 37.27 | 22167270 | |
23 | Acetylation | PSSPCSVKHSPTRET CCCCCCCCCCCCHHH | 23.28 | 21466224 | |
25 | Phosphorylation | SPCSVKHSPTRETLT CCCCCCCCCCHHHEE | 23.42 | 23401153 | |
27 | Phosphorylation | CSVKHSPTRETLTYA CCCCCCCCHHHEEHH | 44.12 | 22167270 | |
30 | Phosphorylation | KHSPTRETLTYAQAQ CCCCCHHHEEHHHHH | 22.55 | 24117733 | |
32 | Phosphorylation | SPTRETLTYAQAQRM CCCHHHEEHHHHHHH | 25.00 | 30576142 | |
33 | Phosphorylation | PTRETLTYAQAQRMV CCHHHEEHHHHHHHE | 10.38 | 30576142 | |
33 (in isoform 2) | Phosphorylation | - | 10.38 | 27642862 | |
66 | Phosphorylation | IILEDDLTAQEMSEC HHHCCCCCHHHHHHH | 33.03 | 28348404 | |
71 | Phosphorylation | DLTAQEMSECNSNKE CCCHHHHHHHHCCCC | 37.94 | 26074081 | |
75 | Phosphorylation | QEMSECNSNKENSER HHHHHHHCCCCCCCC | 62.02 | 25849741 | |
100 | Acetylation | KNNRVKKKNEALPSA CCCCCCCCCCCCCCC | 55.06 | 26051181 | |
106 | Phosphorylation | KKNEALPSAHGTPAS CCCCCCCCCCCCCCC | 33.47 | 29496963 | |
110 | Phosphorylation | ALPSAHGTPASASAL CCCCCCCCCCCCCCC | 13.05 | 29496963 | |
113 | Phosphorylation | SAHGTPASASALPEP CCCCCCCCCCCCCCC | 24.78 | 27732954 | |
115 | Phosphorylation | HGTPASASALPEPKV CCCCCCCCCCCCCCE | 28.04 | 27732954 | |
127 | Phosphorylation | PKVRIVEYSPPSAPR CCEEEEEECCCCCCC | 18.64 | 28102081 | |
128 | Phosphorylation | KVRIVEYSPPSAPRR CEEEEEECCCCCCCC | 19.48 | 29255136 | |
131 | Phosphorylation | IVEYSPPSAPRRPPV EEEECCCCCCCCCCC | 55.05 | 25159151 | |
277 | Acetylation | DCVLCPNKGGAFKKT CEEECCCCCCCCCCC | 43.81 | 26822725 | |
324 | Acetylation | NIPPARWKLTCYLCK CCCHHHHEEEEHHHC | 28.50 | 23749302 | |
328 | Phosphorylation | ARWKLTCYLCKQKGV HHHEEEEHHHCCCCC | 15.20 | - | |
331 | Acetylation | KLTCYLCKQKGVGAC EEEEHHHCCCCCCEE | 53.07 | 23749302 | |
333 | Acetylation | TCYLCKQKGVGACIQ EEHHHCCCCCCEEEE | 40.85 | 26051181 | |
343 | Acetylation | GACIQCHKANCYTAF CEEEEECCCCCEEEE | 49.25 | 25953088 | |
357 | Acetylation | FHVTCAQKAGLYMKM EEHHHHHHCCEEEEE | 26.37 | 25953088 | |
361 | Phosphorylation | CAQKAGLYMKMEPVK HHHHCCEEEEEEEEE | 8.18 | 29759185 | |
363 | Acetylation | QKAGLYMKMEPVKEL HHCCEEEEEEEEEEC | 26.93 | 25953088 | |
368 | Ubiquitination | YMKMEPVKELTGGGT EEEEEEEEECCCCCC | 58.69 | 21890473 | |
368 | Acetylation | YMKMEPVKELTGGGT EEEEEEEEECCCCCC | 58.69 | 19608861 | |
368 | Ubiquitination | YMKMEPVKELTGGGT EEEEEEEEECCCCCC | 58.69 | 21890473 | |
368 (in isoform 2) | Ubiquitination | - | 58.69 | - | |
407 | Acetylation | IYGDVEMKNGVCRKE EECCEEEECCEECCC | 36.72 | 23749302 | |
413 | Acetylation | MKNGVCRKESSVKTV EECCEECCCCCCCHH | 57.74 | 23749302 | |
415 | Phosphorylation | NGVCRKESSVKTVRS CCEECCCCCCCHHHC | 43.39 | - | |
416 | Phosphorylation | GVCRKESSVKTVRST CEECCCCCCCHHHCH | 28.82 | - | |
418 | Acetylation | CRKESSVKTVRSTSK ECCCCCCCHHHCHHH | 43.16 | 23749302 | |
422 | O-linked_Glycosylation | SSVKTVRSTSKVRKK CCCCHHHCHHHHHHH | 32.47 | 30379171 | |
422 | Phosphorylation | SSVKTVRSTSKVRKK CCCCHHHCHHHHHHH | 32.47 | - | |
446 | Phosphorylation | EPCAVLPTVCAPYIP CCCCCCCCCCCCCCC | 24.85 | - | |
451 | Phosphorylation | LPTVCAPYIPPQRLN CCCCCCCCCCHHHHH | 13.92 | - | |
486 | Phosphorylation | YWLLKRLSRNGAPLL HHHHHHHHHCCHHHH | 27.94 | 26029660 | |
498 | Phosphorylation | PLLRRLQSSLQSQRS HHHHHHHHHHHHHHH | 37.29 | 25884760 | |
499 | Phosphorylation | LLRRLQSSLQSQRSS HHHHHHHHHHHHHHH | 19.91 | 30266825 | |
502 | Phosphorylation | RLQSSLQSQRSSQQR HHHHHHHHHHHHHHH | 32.62 | 30266825 | |
516 | Acetylation | RENDEEMKAAKEKLK HHCHHHHHHHHHHHH | 48.77 | 19608861 | |
519 | Acetylation | DEEMKAAKEKLKYWQ HHHHHHHHHHHHHHH | 61.31 | 19608861 | |
521 | Acetylation | EMKAAKEKLKYWQRL HHHHHHHHHHHHHHH | 49.96 | 26051181 | |
523 | Acetylation | KAAKEKLKYWQRLRH HHHHHHHHHHHHHHH | 56.35 | 19608861 | |
523 | Ubiquitination | KAAKEKLKYWQRLRH HHHHHHHHHHHHHHH | 56.35 | - | |
523 (in isoform 2) | Ubiquitination | - | 56.35 | - | |
554 | Acetylation | KLKREQVKVEQVAME HHHHHHCCHHHHHHH | 39.48 | 23749302 | |
554 | Sumoylation | KLKREQVKVEQVAME HHHHHHCCHHHHHHH | 39.48 | 28112733 | |
554 | Ubiquitination | KLKREQVKVEQVAME HHHHHHCCHHHHHHH | 39.48 | - | |
581 | Acetylation | VLDQLQDKDPARIFA HHHHHCCCCHHHHHC | 53.29 | 26051181 | |
594 | Acetylation | FAQPVSLKEVPDYLD HCCCCCHHHCCHHHH | 49.51 | 26051181 | |
594 | Sumoylation | FAQPVSLKEVPDYLD HCCCCCHHHCCHHHH | 49.51 | 28112733 | |
594 | Ubiquitination | FAQPVSLKEVPDYLD HCCCCCHHHCCHHHH | 49.51 | - | |
604 | Acetylation | PDYLDHIKHPMDFAT CHHHHHCCCCCCHHH | 37.93 | 25953088 | |
614 | Acetylation | MDFATMRKRLEAQGY CCHHHHHHHHHHCCC | 50.98 | 19813111 | |
622 | Acetylation | RLEAQGYKNLHEFEE HHHHCCCCCHHHHHH | 60.91 | 19813121 | |
641 | Phosphorylation | IIDNCMKYNARDTVF HHHCHHHCCCCCCEE | 6.28 | 26074081 | |
732 | Acetylation | LDLTCAMKSSGSRSK HHHHHHHHCCCCHHH | 23.97 | 25953088 | |
754 | Acetylation | EIALLRNKLSQQHSQ HHHHHHHHHHHHCCC | 42.98 | 25953088 | |
754 | Ubiquitination | EIALLRNKLSQQHSQ HHHHHHHHHHHHCCC | 42.98 | - | |
756 | Phosphorylation | ALLRNKLSQQHSQPL HHHHHHHHHHCCCCC | 29.42 | 26714015 | |
756 (in isoform 2) | Phosphorylation | - | 29.42 | 22210691 | |
760 | Phosphorylation | NKLSQQHSQPLPTGP HHHHHHCCCCCCCCC | 29.20 | 26714015 | |
760 (in isoform 2) | Phosphorylation | - | 29.20 | 22210691 | |
790 (in isoform 2) | Phosphorylation | - | 40.78 | 29507054 | |
793 | Phosphorylation | EVLPRLETLLQPRKR HHHHHHHHHHCCCCC | 37.04 | 26074081 | |
801 | Phosphorylation | LLQPRKRSRSTCGDS HHCCCCCCCCCCCCC | 33.35 | 23401153 | |
803 | Phosphorylation | QPRKRSRSTCGDSEV CCCCCCCCCCCCCCC | 29.33 | 23401153 | |
804 | Phosphorylation | PRKRSRSTCGDSEVE CCCCCCCCCCCCCCC | 21.28 | 23927012 | |
808 | Phosphorylation | SRSTCGDSEVEEESP CCCCCCCCCCCCCCC | 28.91 | 20164059 | |
814 | Phosphorylation | DSEVEEESPGKRLDA CCCCCCCCCCCCCCC | 42.08 | 23927012 | |
817 | Acetylation | VEEESPGKRLDAGLT CCCCCCCCCCCCCCC | 53.85 | 25953088 | |
832 | Phosphorylation | NGFGGARSEQEPGGG CCCCCCCCCCCCCCC | 43.00 | - | |
837 (in isoform 2) | Phosphorylation | - | 41.89 | 22210691 | |
839 (in isoform 2) | Phosphorylation | - | 30.76 | 22210691 | |
845 | Phosphorylation | GGLGRKATPRRRCAS CCCCCCCCCCCCCCC | 21.99 | 27282143 | |
852 | Phosphorylation | TPRRRCASESSISSS CCCCCCCCCCCCCCC | 41.45 | 27273156 | |
854 | Phosphorylation | RRRCASESSISSSNS CCCCCCCCCCCCCCC | 30.40 | 27273156 | |
855 | Phosphorylation | RRCASESSISSSNSP CCCCCCCCCCCCCCC | 23.57 | 27273156 | |
857 | Phosphorylation | CASESSISSSNSPLC CCCCCCCCCCCCCCC | 29.66 | 28102081 | |
858 | Phosphorylation | ASESSISSSNSPLCD CCCCCCCCCCCCCCC | 31.69 | 28102081 | |
859 | Phosphorylation | SESSISSSNSPLCDS CCCCCCCCCCCCCCC | 34.24 | 27273156 | |
861 | Phosphorylation | SSISSSNSPLCDSSF CCCCCCCCCCCCCCC | 22.61 | 23403867 | |
866 | Phosphorylation | SNSPLCDSSFNAPKC CCCCCCCCCCCCCCC | 35.51 | 23403867 | |
867 | Phosphorylation | NSPLCDSSFNAPKCG CCCCCCCCCCCCCCC | 14.85 | 23403867 | |
875 (in isoform 2) | Phosphorylation | - | 60.47 | 22210691 | |
877 | Acetylation | APKCGRGKPALVRRH CCCCCCCCCCHHCCC | 26.25 | 23749302 | |
881 (in isoform 2) | Phosphorylation | - | 5.70 | 20860994 | |
882 (in isoform 2) | Phosphorylation | - | 26.05 | 25159151 | |
885 | Phosphorylation | PALVRRHTLEDRSEL CCHHCCCCCCCHHHH | 29.99 | 27273156 | |
888 (in isoform 2) | Phosphorylation | - | 63.62 | 30177828 | |
890 | Phosphorylation | RHTLEDRSELISCIE CCCCCCHHHHHHHHH | 49.42 | 29214152 | |
890 (in isoform 2) | Phosphorylation | - | 49.42 | 30177828 | |
892 (in isoform 2) | Phosphorylation | - | 3.54 | 30177828 | |
894 | Phosphorylation | EDRSELISCIENGNY CCHHHHHHHHHCCCH | 22.97 | 23882029 | |
900 (in isoform 2) | Phosphorylation | - | 45.21 | 28111955 | |
902 (in isoform 2) | Phosphorylation | - | 10.06 | 30266825 | |
903 | Acetylation | IENGNYAKAARIAAE HHCCCHHHHHHHHHH | 32.02 | 19608861 | |
905 (in isoform 2) | Phosphorylation | - | 11.60 | 30266825 | |
906 (in isoform 2) | Phosphorylation | - | 24.76 | 30266825 | |
911 (in isoform 2) | Phosphorylation | - | 7.88 | 27987026 | |
915 | Phosphorylation | AAEVGQSSMWISTDA HHHHCCCCEEECCHH | 15.39 | 23532336 | |
920 | Phosphorylation | QSSMWISTDAAASVL CCCEEECCHHHHHHH | 22.11 | 23532336 | |
932 (in isoform 2) | Phosphorylation | - | 5.98 | 25159151 | |
936 | Acetylation | PLKVVWAKCSGYPSY CHHHHEEECCCCCCC | 17.14 | 25953088 | |
951 | Acetylation | PALIIDPKMPRVPGH CEEEECCCCCCCCCC | 58.76 | 26051181 | |
981 | Acetylation | IGEHMQTKSDEKLFL ECCCCCCCCCCCEEE | 38.73 | 23749302 | |
995 | Acetylation | LVLFFDNKRSWQWLP EEEEECCCCCEEECC | 50.05 | 11925801 | |
1003 | Acetylation | RSWQWLPKSKMVPLG CCEEECCHHCCEECC | 61.61 | 26051181 | |
1005 | Acetylation | WQWLPKSKMVPLGID EEECCHHCCEECCCC | 50.47 | 25953088 | |
1016 (in isoform 2) | Phosphorylation | - | 58.62 | - | |
1017 | Ubiquitination | GIDETIDKLKMMEGR CCCHHHHHHHHHCCC | 46.27 | - | |
1026 | Phosphorylation | KMMEGRNSSIRKAVR HHHCCCCHHHHHHHH | 26.28 | 21406692 | |
1027 | Phosphorylation | MMEGRNSSIRKAVRI HHCCCCHHHHHHHHH | 29.93 | 21406692 | |
1051 | Phosphorylation | SRVHGEPTSDLSDID HHHCCCCCCCCCCCC | 30.48 | 22167270 | |
1052 | Phosphorylation | RVHGEPTSDLSDID- HHCCCCCCCCCCCC- | 47.47 | 22167270 | |
1055 | Phosphorylation | GEPTSDLSDID---- CCCCCCCCCCC---- | 37.19 | 22167270 | |
1126 (in isoform 2) | Acetylation | - | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BRD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BRD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BRD1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-368; LYS-418; LYS-516;LYS-519; LYS-523 AND LYS-903, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128 AND SER-1055, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128; THR-1051 ANDSER-1055, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1052 AND SER-1055, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. |